Navegar

Colección

Datos Estadísticas

Lista de

hyperprolactinemia
13
"Chronic hyperprolactinemia evoked by disruption of lactotrope dopamine d2 receptors impacts on liver and adipocyte genes related to glucose and insulin balance" (2016) Luque, G.M.;Lopez-Vicchi, F.;María Ornstein, A. (...)Becu-Villalobos, D. American Journal of Physiology - Endocrinology and Metabolism. 311(6):E974-E988
"Chronic hyperprolactinemia evoked by disruption of lactotrope dopamine d2 receptors impacts on liver and adipocyte genes related to glucose and insulin balance" (2016) Luque, G.M.;Lopez-Vicchi, F.;María Ornstein, A. (...)Becu-Villalobos, D. American Journal of Physiology - Endocrinology and Metabolism. 311(6):E974-E988
"Chronic hyperprolactinemia evoked by disruption of lactotrope dopamine d2 receptors impacts on liver and adipocyte genes related to glucose and insulin balance" (2016) Luque, G.M.;Lopez-Vicchi, F.;María Ornstein, A. (...)Becu-Villalobos, D. American Journal of Physiology - Endocrinology and Metabolism. 311(6):E974-E988
"Selective disruption of dopamine D2 receptors in pituitary lactotropes increases body weight and adiposity in female mice" (2014) Millan, M.I.P.;Luque, G.M.;Ramirez, M.C. (...)Becu-Villalobos, D. Endocrinology. 155(3):829-839
"Active and total transforming growth factor-β1 are differentially regulated by dopamine and estradiol in the pituitary" (2011) Recouvreux, M.V.;Guida, M.C.;Rifkin, D.B. (...)Díaz-Torga, G. Endocrinology. 152(7):2722-2730
"Neurotransmitter modulation of the GHRH-GH axis" (2010) García-Tornadu, I.;Risso, G.;Perez-Millan, M.I. (...)Guitelman M. Frontiers of Hormone Research. 38:59-69
"New insights into the endocrine and metabolic roles of dopamine D2 receptors gained from the Drd2-/- mouse" (2010) Garcia-Tornadú, I.;Perez-Millan, M.I.;Recouvreux, V. (...)Becu-Villalobos, D. Neuroendocrinology. 92(4):207-214
"Fibroblast growth factor-2 in hyperplastic pituitaries of D2R knockout female mice" (2007) Cristina, C.;Díaz-Torga, G.;Góngora, A. (...)Becu-Villalobos, D. American Journal of Physiology - Endocrinology and Metabolism. 293(5):E1341-E1351
"PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes" (2007) Cristina, C.;Díaz-Torga, G.S.;Goya, R.G. (...)Becu-Villalobos, D. Molecular Cancer. 6
"Signaling processes in tumoral neuroendocrine pituitary cells as potential targets for therapeutic drugs" (2005) Paez-Pereda, M.;Giacomini, D.;Echenique, C. (...)Arzt, E. Current Drug Targets: Immune, Endocrine and Metabolic Disorders. 5(3):259-267
"Dehydroepiandrosterone treatment attenuates oestrogen-induced pituitary hyperplasia" (2002) Suárez, C.; García Tornadú, I.; Khalil, W.; Becu-Villalobos, D. Journal of Endocrinology. 174(3):447-454
"Octopamine and Phenylethylamine Inhibit Prolactin Secretion both In Vivo and In Vitro" (1992) Becú-Villalobos, D.;Thyssen, S.M.;Rey, E.B. (...)Libertun, C. Proceedings of the Society for Experimental Biology and Medicine. 199(2):230-235
"Effect of median eminence lesions and hormonal replacement on the prolactin receptors in the adrenal Gland and langerhans islets from ovariectomized adult rats" (1985) Lüthy, I.A.;Tesone, M.;Oliveira-Filho, R.M. (...)Calandra, R.S. Journal of Receptors and Signal Transduction. 5(1):105-119